{
    "nctId": "NCT03381755",
    "officialTitle": "Comparative Effectiveness and Safety Analysis of Low-dose and Standard-dose Ticagrelor in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention",
    "inclusionCriteria": "* After half-dose ticagrelor (loading dose 90mg, and then 45mg bidpo.) treatment for 3 days, the platelet aggregation is effectively inhibited by light transmission aggregometry method and thromboela-stogram.\n* planned to undergo PCI recently\n* planned to DAPT for 1 year after PCI\n* Must have minimum age of 18 Years\n* Must have maximum age of 75 Years",
    "exclusionCriteria": "* taken adenosine diphosphate (ADP) receptor antagonists within 2 weeks\n* Platelet count \\<100g/L;\n* A history of bleeding tendency;\n* Aspirin, ticagrelor or clopidogrel allergies;\n* Severe liver injury."
}